# Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride

> **NCT02263547** · PHASE1 · TERMINATED · sponsor: **Derrick Scott Robertson** · enrollment: 14 (actual)

## Conditions studied

- Teriflunomide Elimination
- Healthy Volunteers

## Interventions

- **DRUG:** teriflunomide
- **DRUG:** Colestipol

## Key facts

- **NCT ID:** NCT02263547
- **Lead sponsor:** Derrick Scott Robertson
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** PK time points were not being met as expected. Determination that risks outweighed benefit.
- **Last updated:** 2020-04-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02263547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02263547, "Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02263547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*